New York State Common Retirement Fund
KZR

New York State Common Retirement Fund’s Kezar Life Sciences KZR Stock Holding History

New York State Common Retirement Fund’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-61
Closed -$363 – 3281
2024
Q2 		$363 Sell
61
-2,314
-97% -$17.6K ﹤0.01% 3357
2024
Q1 		$21.4K Hold
2,375
– – ﹤0.01% 3137
2023
Q4 		$22.5K Sell
2,375
-14
-0.6% -$123 ﹤0.01% 3137
2023
Q3 		$28.4K Buy
2,389
+29
+1% +$514 ﹤0.01% 3140
2023
Q2 		$57.8K Hold
2,360
– – ﹤0.01% 3104
2023
Q1 		$73.9K Sell
2,360
-1,450
-38% -$83.9K ﹤0.01% 2896
2022
Q4 		$268K Buy
3,810
+5
+0.1% +$371 ﹤0.01% 2594
2022
Q3 		$328K Buy
3,805
+1,105
+41% +$107K ﹤0.01% 2548
2022
Q2 		$223K Sell
2,700
-6
-0.2% -$529 ﹤0.01% 2750
2022
Q1 		$450K Buy
2,706
+689
+34% +$98.9K ﹤0.01% 2451
2021
Q4 		$337K Sell
2,017
-10
-0.5% -$1.13K ﹤0.01% 2648
2021
Q3 		$175K Buy
2,027
+12
+0.6% +$794 ﹤0.01% 2960
2021
Q2 		$109K Buy
2,015
+25
+1% +$1.42K ﹤0.01% 3196
2021
Q1 		$119K Hold
1,990
– – ﹤0.01% 3010
2020
Q4 		$104K Buy
1,990
+720
+57% +$40.1K ﹤0.01% 3006
2020
Q3 		$61K Hold
1,270
– – ﹤0.01% 3098
2020
Q2 		$66K Hold
1,270
– – ﹤0.01% 3115
2020
Q1 		$55K Hold
1,270
– – ﹤0.01% 2960
2019
Q4 		$51K Hold
1,270
– – ﹤0.01% 3127
2019
Q3 		$42K Hold
1,270
– – ﹤0.01% 3170
2019
Q2 		$98K Buy
1,270
+960
+310% +$149K ﹤0.01% 3121
2019
Q1 		$55K Hold
310
– – ﹤0.01% 3063
2018
Q4 		$73K Buy
+310
New +$75.8K ﹤0.01% 3034

Other funds holding KZR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

New York State Common Retirement Fund's KZR Position: Q3 2024 in Review

New York State Common Retirement Fund sold out of Kezar Life Sciences (KZR) in Q3 2024, closing a stake of 61 shares — an estimated $363 sold.

New York State Common Retirement Fund first reported a position in KZR in Q4 2018 and held it in 23 quarters. The position peaked at $450K in Q1 2022. 59 funds tracked by Wall St. Rank hold KZR as of Q3 2024.

  • New York State Common Retirement Fund reported no remaining Kezar Life Sciences position as of Q3 2024 after selling out during the quarter.
  • New York State Common Retirement Fund sold 61 Kezar Life Sciences shares in Q3 2024, an estimated $363.
  • New York State Common Retirement Fund first reported a position in Kezar Life Sciences in Q4 2018 and held it in 23 quarters.
  • New York State Common Retirement Fund's Kezar Life Sciences position peaked at $450K in Q1 2022.
  • 59 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q3 2024.

Based on New York State Common Retirement Fund's 13F filing for Q3 2024, filed 28 Oct 2024.